CITRIS Foundry logo

CITRIS Foundry

North America, California, United States, Berkeley

Description

CITRIS Foundry is a prominent deep tech startup accelerator based in Berkeley, California, operating under the umbrella of the Center for Information Technology Research in the Interest of Society and the Banatao Institute (CITRIS and the Banatao Institute) at the University of California, Berkeley. Established as a vital component of UC Berkeley's innovation ecosystem, the Foundry is dedicated to bridging the gap between cutting-edge academic research and commercial viability. Its core mission revolves around empowering deep tech founders by providing them with the essential resources, expert mentorship, and a robust network necessary to translate their groundbreaking research into scalable, impactful ventures.

The accelerator program is specifically designed for early-stage startups leveraging complex scientific and engineering breakthroughs. Participants benefit from a structured curriculum that guides them through critical phases of product development, market validation, and business strategy. A distinguishing feature of the CITRIS Foundry is its commitment to non-dilutive support, meaning it does not take equity from the startups it nurtures. This approach allows founders to retain full ownership of their intellectual property and company, which is particularly appealing to research-intensive ventures.

Financial support from the CITRIS Foundry comes in the form of non-dilutive grants, specifically up to $2,000 per startup. This funding is primarily intended to facilitate crucial early-stage activities such as prototyping and customer discovery, enabling teams to validate their concepts and build initial versions of their technology without immediate equity concerns. Since its inception in 2014, the CITRIS Foundry has played a significant role in fostering innovation, having supported the launch of over 100 startups. This track record underscores its effectiveness in transforming academic ingenuity into viable commercial enterprises, contributing significantly to the deep tech landscape.

The Foundry's model emphasizes long-term growth and sustainability for its portfolio companies, leveraging the vast academic and research capabilities of UC Berkeley. By focusing on non-dilutive capital and comprehensive support, CITRIS Foundry positions itself not as a traditional venture capital investor, but as a crucial early-stage catalyst for deep technology, preparing startups for subsequent rounds of investment from external sources.

Investor Profile

CITRIS Foundry has backed more than 95 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Non Equity Assistance, Pre Seed, Series A rounds (top funding stages).
  • Majority of deals are located in United States, India, Germany.
  • Strong thematic focus on Health Care, Software, Information Technology.
  • Typical check size: $2K.

Stage Focus

  • Non Equity Assistance (96%)
  • Pre Seed (2%)
  • Series A (1%)
  • Grant (1%)

Country Focus

  • United States (72%)
  • India (1%)
  • Germany (1%)
  • Canada (1%)
  • Japan (1%)
  • The Netherlands (1%)
  • El Salvador (1%)

Industry Focus

  • Health Care
  • Software
  • Information Technology
  • Biotechnology
  • Medical
  • Artificial Intelligence (Ai)
  • Energy
  • Renewable Energy
  • Education
  • Machine Learning
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does CITRIS Foundry frequently co-invest with?

Pear VC
North America, California, United States, Menlo Park
Co-Investments: 1
Mayfield Fund
North America, California, United States, Menlo Park
Co-Investments: 1
SkyDeck Berkeley
North America, California, United States, Berkeley
Co-Investments: 9
GSR Ventures
North America, California, United States, Menlo Park
Co-Investments: 1
Berkeley Angel Network
North America, California, United States, San Francisco
Co-Investments: 1
Global IoT Technology Ventures, Inc.
Asia, Tokyo, Japan, Tokyo
Co-Investments: 1
Dorm Room Fund
North America, Pennsylvania, United States, Philadelphia
Co-Investments: 1
Plug and Play
North America, California, United States, Sunnyvale
Co-Investments: 1
OUP (Osage University Partners)
North America, Pennsylvania, United States, Bala Cynwyd
Co-Investments: 1
Co-Investments: 1

What are some of recent deals done by CITRIS Foundry?

Aila Health

San Francisco, California, United States

Aila Health is a virtual-first specialty care company for people living with autoimmune conditions

AnalyticsAppsArtificial Intelligence (AI)Health CareHospitalmHealthMobile AppsPersonal HealthWellness
Pre SeedNov 27, 2021
Amount Raised: $80,000

UI GO! provides interactive tools to help communities and agencies respond to wildfire events.

Field SupportService Industry
Non Equity AssistanceFeb 15, 2021
Loggicat

San Francisco, California, United States

Loggicat helps technology companies improve their log security.

Information TechnologyPrivacySecurity
Non Equity AssistanceFeb 15, 2021
Sunchem

Amsterdam, Noord-Holland, The Netherlands

Sunchem is an industrial research and develop company operating in the sector of genetic applied to plant for energy purposes.

EnergyOil and Gas
Non Equity AssistanceFeb 15, 2021
Sundial Foods

Berkeley, California, United States

Sundial Foods utilizes a macro and microstructural engineering approach to create plant-based meat alternatives for conscious consumers.

Alternative ProteinFood and BeverageFood ProcessingOrganic Food
Non Equity AssistanceFeb 15, 2021
Procuros

Hamburg, Hamburg, Germany

Connect Once. Integrate all trade Partners. - The new standard in B2B transactions

Software
Non Equity AssistanceFeb 15, 2021

Irritector helps companies assess water usage and sustainability in agriculture.

AgricultureFarmingWater
Non Equity AssistanceFeb 15, 2021
OrganOmics

South San Francisco, California, United States

OrganOmics engages in drug discovery rooted in precision medicine.

BiotechnologyHealth CareMedicalPrecision MedicineTherapeutics
Non Equity AssistanceFeb 15, 2021

myPRS utilizes polygenic risk scores to help families understand their children’s genetic predisposition to diseases.

GeneticsHealth CareMedical
Non Equity AssistanceFeb 15, 2021
Chemix

Sagamihara, Kanagawa, Japan

Chemix has developed and commercialised a heat dissipation and insulation material.

Fuel CellManufacturing
Non Equity AssistanceFeb 15, 2021